Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06552481 · ClinicalTrials.gov registry record · NA
A Case-Control Study of Negative Pressure Platform Wound Devices (NP-PWD) for Skin and Soft Tissue Defects
A NA study of Skin Wound and Soft Tissue Injuries, sponsored by The Metis Foundation.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT06552481: Completed NA study of Skin Wound and Soft Tissue Injuries, sponsored by The Metis Foundation.
NCT06552481 is a NA study of Skin Wound and Soft Tissue Injuries that has completed, run by The Metis Foundation. The registered enrollment target is 28 participants, above the 19-participant average among 5 other Skin Wound trials with a reported enrollment target (47% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06552481, a NA study of Skin Wound and Soft Tissue Injuries, has completed, sponsored by The Metis Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will demonstrate the effectiveness of the NP-PWD therapy in managing complex wounds and improving wound healing parameters as compared to standard of care.
Primary Outcome
The number and type of issues with the device will be documented to determine feasibility and usability. Events such as complications with application, device changes and early removal and rationale for events during the period the patient has the study device applied and throughout the entire enrollment period.
Conditions Studied
Interventions
- DEVICE NP-PWD
- DEVICE Wound Vac
Study Locations (1)
Texas
- Northeast Baptist - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2023-08-16 |
| Est. Completion | 2024-04-25 |
| Phase | NA |
What the finished NCT06552481 record still lists
NCT06552481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, above the 19-participant average among 5 other Skin Wound trials with a reported enrollment target (47% higher).
The record links to 2 conditions, with Skin Wound appearing as the primary indexed condition, and to 2 interventions - of which NP-PWD is the first listed.
NCT06552481 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06552481 about?
NCT06552481 is a clinical study titled "A Case-Control Study of Negative Pressure Platform Wound Devices (NP-PWD) for Skin and Soft Tissue Defects". This study will demonstrate the effectiveness of the NP-PWD therapy in managing complex wounds and improving wound healing parameters as compared to standard of care.
What is the current status of trial NCT06552481?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2023-08-16. Estimated completion is 2024-04-25.
What conditions does trial NCT06552481 study?
This clinical trial studies the following conditions: Skin Wound, Soft Tissue Injuries.
What interventions are being tested in trial NCT06552481?
The interventions under investigation include: NP-PWD (DEVICE), Wound Vac (DEVICE).
Who is sponsoring clinical trial NCT06552481?
This trial is sponsored by The Metis Foundation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06552481 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Limb Health and Socket Pressure in Response to Powered Ankle Protheses
COMPLETED · NA
-
Autologous Volar Fibroblast Injection Into the Stump Site of Amputees
RECRUITING · Phase 2
-
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
COMPLETED · Phase 1
-
StrataGraft Safety, Tolerability and Efficacy in Pediatric Subjects
COMPLETED · Phase 3
-
Amnion Wound Covering for Enhanced Wound Healing
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI